Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish
JournalDisease models & mechanisms
PublisherThe Company of Biologists
MetadataShow full item record
AbstractThe adult zebrafish is an emerging vertebrate model for studying human cardiomyopathies; however, whether the simple zebrafish heart can model different subtypes of cardiomyopathies, such as dilated cardiomyopathy (DCM), remains elusive. Here, we generated and characterized an inherited DCM model in adult zebrafish and used this model to search for therapeutic strategies. We employed transcription activator-like effector nuclease (TALEN) genome editing technology to generate frame-shift mutants for the zebrafish ortholog of human BCL2-associated athanogene 3 (BAG3), an established DCM-causative gene. As in mammals, the zebrafish bag3 homozygous mutant (bag3e2/e2 ) exhibited aberrant proteostasis, as indicated by impaired autophagy flux and elevated ubiquitinated protein aggregation. Through comprehensive phenotyping analysis of the mutant, we identified phenotypic traits that resembled DCM phenotypes in mammals, including cardiac chamber enlargement, reduced ejection fraction characterized by increased end-systolic volume/body weight (ESV/BW), and reduced contractile myofibril activation kinetics. Nonbiased transcriptome analysis identified the hyperactivation of the mechanistic target of rapamycin (mTOR) signaling in bag3e2/e2 mutant hearts. Further genetic studies showed that mtorxu015/+ , an mTOR haploinsufficiency mutant, repaired abnormal proteostasis, improved cardiac function and rescued the survival of the bag3e2/e2 mutant. This study established the bag3e2/e2 mutant as a DCM model in adult zebrafish and suggested mtor as a candidate therapeutic target gene for BAG3 cardiomyopathy.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85072993325&doi=10.1242%2fdmm.040154&partnerID=40&md5=45c5c1f2b86753a5d7455a907fb959e9; http://hdl.handle.net/10713/11161
- Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.
- Authors: Diofano F, Weinmann K, Schneider I, Thiessen KD, Rottbauer W, Just S
- Issue date: 2020 Nov
- Whole exome sequencing identified 1 base pair novel deletion in BCL2-associated athanogene 3 (BAG3) gene associated with severe dilated cardiomyopathy (DCM) requiring heart transplant in multiple family members.
- Authors: Rafiq MA, Chaudhry A, Care M, Spears DA, Morel CF, Hamilton RM
- Issue date: 2017 Mar
- Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish.
- Authors: Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, Sivasubbu S, Lin X, Ekker S, Xu X
- Issue date: 2011 Sep 2
- P209L mutation in Bag3 does not cause cardiomyopathy in mice.
- Authors: Fang X, Bogomolovas J, Zhou PS, Mu Y, Ma X, Chen Z, Zhang L, Zhu M, Veevers J, Ouyang K, Chen J
- Issue date: 2019 Feb 1
- Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy.
- Authors: Dvornikov AV, Wang M, Yang J, Zhu P, Le T, Lin X, Cao H, Xu X
- Issue date: 2019 Aug